
Closed
Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder
Innovative neurodegeneration research support
Offered by Official source: researchnet-recherchenet.ca
Canadian Institutes of Health Research (CIHR)
Record updated
- Funding available
- $ 360,000
- Deadline
- Unspecified
- Location
- Canada
- Who can apply
- Lead Canadian Principal Applicant (Nominated Principal Applicant) who is a member of the Canadian Consortium on Neurodegeneration in Aging (CCNA) in one of these roles: Nominated Principal Investigator, Principal Investigator, or Co-Applicant.
- See full eligibility
Overview
The Catalyst Grant: COEN Initiative — Pathfinder supports innovative neurodegeneration research on Alzheimer’s disease and related dementia across at least two partner countries, with the Canadian portion offering up to $180,000 per year for 2 years. It is intended for a Lead Canadian Principal Applicant in the Canadian Consortium on Neurodegeneration in Aging.
At a glance
Funding available
- Maximum funding
- $360,000
- Develop strategic partnerships
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible candidates
- Location
- Canada
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- 2SLGBTQI+
- Legal structures
- All legal structures
Receipt of requests is now closed
Get notified about updates to this grant.
Availability timeline
2016
Periods: 1
Eligibility
Who is eligible?
- Lead Canadian Principal Applicant (Nominated Principal Applicant) who is a member of the Canadian Consortium on Neurodegeneration in Aging (CCNA) in one of these roles: Nominated Principal Investigator, Principal Investigator, or Co-Applicant.
Activities funded
- Research on the latest preventive, diagnostic, and treatment approaches to Alzheimer’s disease and related dementia.
- High-risk, high-payoff research that encourages new and unconventional approaches and creative solutions to neurodegeneration research challenges.
- Collaborative research that combines the strengths of centres of excellence in neurodegeneration in at least two partner countries.
How to apply
- Submit the application to COEN.
- Canadian applicants must also complete an abbreviated CIHR application and submit it using ResearchNet.
- Upload the signed signature pages, including the routing slip, in the Print/Upload Signature Pages task in ResearchNet before submitting the application.
- Complete the mandatory ResearchNet tasks: Identify Participants, Enter Proposal Information, Complete Summary of Research Proposal, Enter Budget Information, Print, sign and upload Signature Pages, Preview Application Materials, and Consent and Submit Application.
Documents Needed
- Signed signature pages, including the routing slip.
- A Summary of Research Proposal of one page maximum.
- An operating budget for the project in Canadian dollars, with a complete justification for funds requested.
Selection criteria
- CIHR and its partners conduct a relevance review before peer review.
- Applications deemed relevant will be funded from the top down as far as budgets allow.
Processing and Agreement
- CIHR and its partners will conduct a relevance review before peer review using application and nominative information.
- Successful applicants and any other persons working on the project must comply fully with CIHR Funding Policies.
- Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive the Authorization for Funding (AFF) document.
- The Lead Canadian Principal Applicant must submit an electronic Final Report to CIHR.
- The Nominated Principal Applicant must participate in monitoring, review, and evaluation activities and encourage associates, trainees, and administration to participate as required.
Additional information
- The initiative is part of the CIHR Dementia Research Strategy and is funded through CIHR’s Roadmap Accelerator Fund.
- Scientific leadership is provided by the Institute of Aging and the Institute of Neurosciences, Mental Health and Addiction.
- Applicants are encouraged to use Gender and Sex-Based Analysis in their applications.
- CIHR encourages researchers to involve citizens where appropriate and to consider Official Languages and Official Language Minority Communities where appropriate.
Contacts
Official sources
Frequently Asked Questions about the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder Program
What is the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder?
The Catalyst Grant: COEN Initiative — Pathfinder supports innovative neurodegeneration research on Alzheimer’s disease and related dementia across at least two partner countries, with the Canadian portion offering up to $180,000 per year for 2 years. It is intended for a Lead Canadian Principal Applicant in the Canadian Consortium on Neurodegeneration in Aging.
How much funding can be received?
Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder Funds up to $360,000 of admissible expenses.
Who is eligible for the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder program?
To be eligible for the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder program, you must:
The Lead Canadian Principal Applicant must be a member of the CCNA.
The applicant must hold one of these CCNA roles: Nominated Principal Investigator, Principal Investigator, or Co-Applicant.
The applicant must consent to sharing nominative information at the time of application.
Who can I contact for more information about the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder?
You can contact Canadian Institutes of Health Research (CIHR) by email at laurent.landreville@cihr-irsc.gc.ca or by phone at 613-948-2308.
Where is the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder available?
The Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder program is available across Canada.
Is the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder a grant, loan, or tax credit?
Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder is a Grant and Funding
Who are the financial supporters of the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder?
Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder is funded by Canadian Institutes of Health Research (CIHR)
